Net Loss of Suven Life Sciences reported to Rs 49.64 crore in the quarter ended September 2024 as against net loss of Rs 12.68 crore during the previous quarter ended September 2023. Sales declined 16.01% to Rs 2.57 crore in the quarter ended September 2024 as against Rs 3.06 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2.573.06 -16 OPM %-2031.52-768.30 - PBDT-48.19-18.41 -162 PBT-49.64-20.14 -146 NP-49.64-12.68 -291 Powered by Capital Market - Live News

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 28.04 crore in the quarter ended June 2024 as against net loss of Rs 24.09 crore during the previous quarter ended June 2023. Sales declined 73.42% to Rs 1.01 crore in the quarter ended June 2024 as against Rs 3.80 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1.013.80 -73 OPM %-3023.76-737.11 - PBDT-26.55-22.43 -18 PBT-28.04-24.09 -16 NP-28.04-24.09 -16 Powered by Capital Market - Live News

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live News

Suven Life Sciences announced that the 35th Annual General Meeting(AGM) of the company will be held on 2 August 2024.Powered by Capital Market - Live News